Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Beetroot juice tested as blood pressure aid for pre-eclampsia

NCT ID NCT06387784

Symptom relief Sponsor: University of Sao Paulo Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether beetroot juice can quickly lower blood pressure in pregnant women with pre-eclampsia, a serious condition causing high blood pressure. Researchers will give beetroot juice or a placebo to 60 pregnant women and measure changes in blood pressure, blood markers, and fetal blood flow. The goal is to see if beetroot juice could be a helpful addition to standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

Jul 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 40 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

1. Pre-eclampsia pregnat women Inclusion Criteria: * Pregnant women at or beyond the 20th week of gestation. * Hospitalized at Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto. * Diagnosed with early-onset pre-eclampsia confirmed by a medical professional. * Capacity to provide written informed consent for study participation. Exclusion Criteria: * Multiple pregnancies. * Uncontrolled arterial hypertension (Systolic Blood Pressure \> 160 mmHg or Diastolic Blood Pressure \> 100 mmHg). * Pregnant women with a body mass index \> 40 kg/m² * Severe gestational complications. * History of food allergy with hypersensitivity to beetroot. * Smokers. * Chronic alcohol consumption. * Medications such as non-steroidal anti-inflammatory drugs, nasal decongestants, users of proton pump inhibitors and H2 receptor antagonists or any other medication that interferes with stomach pH. * Diagnosis of renal or hepatic disease affecting nitrate metabolism. * Cardiac conditions such as moderate to severe congestive heart failure and coronary artery disease. * Pre-existing type 1 or type 2 diabetes. 2. Healthy Pregnant Women Inclusion Criteria: * Healthy pregnant women at or beyond the 20th week of gestation. * Absence of pre-eclampsia diagnosis or other obstetric complications. * Willingness and ability to remain admitted at the Clinical Research Unit for the - period required by the study. * Capacity to provide written informed consent for study participation. Exclusion Criteria: \- The same exclusion criteria from Pre-eclampsia group apply.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pre-eclampsia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

preeclampsia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pre-eclampsia Pregnacy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - USP

    Ribeirão Preto, São Paulo, Brazil

  • Hospital das Clínicas de Ribeirão Preto

    Ribeirão Preto, São Paulo, 35180074, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.